Variable expressivity of the tumour suppressor protein TRP53 in cryopreserved human blastocysts
2007

TRP53 Expression in Human Embryos

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): Chandrakanthan Vashe, Chami Omar, Stojanov Tomas, O'Neill Chris

Primary Institution: Human Reproduction Unit, Royal North Shore Hospital, and the Discipline of Physiology, University of Sydney

Hypothesis

Is TRP53 expression in human embryos produced by ICSI a determinant of embryo viability?

Conclusion

The study shows that TRP53 expression varies significantly among human embryos, with higher levels associated with poorer morphology and viability.

Supporting Evidence

  • TRP53 expression is low in early embryos but increases significantly at the blastocyst stage.
  • Embryos with poor morphology showed higher levels of TRP53 staining.
  • The study indicates that TRP53 may negatively impact embryo viability.

Takeaway

Some human embryos show different amounts of a protein called TRP53, and those with more of it tend to not develop well.

Methodology

The study examined 7 embryos from two couples using immunostaining for TRP53 after ICSI and culture.

Limitations

The study cannot exclude the possibility that cryopreservation affected TRP53 expression.

Participant Demographics

Couples treated for male factor infertility (oligozoospermia).

Digital Object Identifier (DOI)

10.1186/1477-7827-5-39

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication